Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Infections with nonthoracotomy implantable cardioverter defibrillators: can these be prevented? Endotak Lead Clinical Investigators.

Smith PN, Vidaillet HJ, Hayes JJ, Wethington PJ, Stahl L, Hull M, Broste SK.

Pacing Clin Electrophysiol. 1998 Jan;21(1 Pt 1):42-55.

PMID:
9474647
3.

A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.

Buxton M, Caine N, Chase D, Connelly D, Grace A, Jackson C, Parkes J, Sharples L.

Health Technol Assess. 2006 Aug;10(27):iii-iv, ix-xi, 1-164. Review.

4.

Infections of implantable cardioverter defibrillators: approach to management.

Spratt KA, Blumberg EA, Wood CA, Kutalek SP, Reboli AC.

Clin Infect Dis. 1993 Oct;17(4):679-85. Review.

PMID:
8268349
5.

Transvenous endocardial cardioverter defibrillator systems. Is the future here?

Manolis AS.

Arch Intern Med. 1994 Mar 28;154(6):617-22. Review.

PMID:
8129494
6.

[Infectious complications of cardioverter/defibrillators--case report and review of the literature].

Hollenstein U, Thalhammer F, Burgmann H, Breyer S.

Acta Med Austriaca. 1996;23(5):164-7. Review. German.

PMID:
9082746
7.

Twiddler's syndrome complicating a transvenous defibrillator lead system.

de Buitleir M, Canver CC.

Chest. 1996 May;109(5):1391-4. Review.

PMID:
8625696
8.

Defibrillator patch electrode constriction: an underrecognized entity.

Barrington WW, Deligonul U, Easley AR, Windle JR.

Ann Thorac Surg. 1995 Oct;60(4):1112-5; discussion 1115-6. Review.

PMID:
7574964
Items per page

Supplemental Content

Write to the Help Desk